ManifestSeven Holdings Corporation MNFSF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score

21/100

0/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

Income Statement Balance Sheet Cash Flow Statement

Annual Quarterly

ManifestSeven Holdings Corporation (MNFSF) generated $28.27K in operating cash flow for quarter ending 2021-08-31. After capital expenditures of $16.23K, free cash flow was $44.5K.

Free cash flow margin was 1.1% of revenue. Cash conversion ratio was -0.02x, suggesting some earnings are non-cash.

Criteria supported by this page:

HEALTH (0/100, Fail) — weak cash flow raises concerns about debt servicing
MOAT (36/100, Fail) — limited free cash flow weakens the competitive position
INCOME (10/100) — Cash conversion ratio was -0.02x suggests some earnings are non-cash items

Overall SharesGrow Score: 20/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score

21/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

0/100

→ Income

✗

HEALTH

0/100

Debt-to-Equity & liquidity

Proven by this page

✗

MOAT

36/100

Proven by this page

GROWTH

58/100

→ Income

✗

INCOME

10/100

→ Income

ManifestSeven Holdings Corporation Cash Flow History

Metric	TTM	Q3 FY2021	Q2 FY2021	Q1 FY2021	Q4 FY2020
Operating Cash Flow	$-8.37M	$28.27K	$-1.93M	$-1.68M	$-4.79M
Capital Expenditure	$-290.89K	$16.23K	$50.94K	$-299.02K	$-59.03K
Free Cash Flow	$-8.66M	$44.5K	$-1.87M	$-1.98M	$-4.85M